Home » Topics » BioWorld Science

BioWorld Science
RSS

Anseculin HCl enters phase II clinical trials

July 5, 1996

Toyama discloses NGF-promoting agents

July 5, 1996

Dolasetron equiefficent to granisetron in chemotherapy-induced emesis

July 5, 1996

Regeneron, Medtronic to collaborate on Axokine delivery system

July 5, 1996

Medeva shareholders OK Rochester take-over

July 5, 1996

Glaxo Wellcome divests interest in Warner Wellcome JV

July 5, 1996

Bracco Diagnostics takes over marketing from Squibb Diagnostics

July 5, 1996

Elan-Athena merger approved by stockholders

July 5, 1996

Horiba to acquire ABX from Roche

July 5, 1996

Alza/HMR and Ciba-Geigy resolve nicotine patch patent disputes

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...